Fireside Chat: Leveraging the Predictive Power of Liquid Biopsy for IO Treatment Response Monitoring
Time: 12:30 pm
day: Day One
Details:
- Challenges with treatment response monitoring today
- Enhancing the predictive power of liquid biopsy with a methylation-based approach to treatment response monitoring
- Learn about Guardant / PICI’s new data, showcasing clinical evidence behind methylation-based tumor fraction for IO response monitoring
- Hear how response monitoring using liquid biopsy can accelerate drug development
